• 1
    Yim D, Curtis N, Cheung M, Burgner D. Update on Kawasaki disease: epidemiology, aetiology and pathogenesis. J. Paediatr. Child Health 2013. doi: 10.1111/jpc.12172
  • 2
    Newburger JW, Takahashi M, Gerber MA et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004; 114: 17081733.
  • 3
    Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364: 533544.
  • 4
    Kato T, Numaguchi A, Ando H et al. Coronary arterial ectasia in a 2-year-old boy showing two symptoms of Kawasaki disease without manifesting fever. Rheumatol. Int. 2012; 32: 11011103.
  • 5
    Japanese Circulation Society Joint Research Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease. Pediatr. Int. 2005; 47: 711732.
  • 6
    Ayusawa M, Sonobe T, Uemura S et al. Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition). Pediatr. Int. 2005; 47: 232234.
  • 7
    Anderson MS, Todd JK, Glode MP. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics 2005; 115: e428433.
  • 8
    Pannaraj PS, Turner CL, Bastian JF, Burns JC. Failure to diagnose Kawasaki disease at the extremes of the pediatric age range. Pediatr. Infect. Dis. J. 2004; 23: 789791.
  • 9
    Baker AL, Lu M, Minich LL et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J. Pediatr. 2009; 154: 5925 e2.
  • 10
    Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS. Infections and Kawasaki disease: implications for coronary artery outcome. Pediatrics 2005; 116: e760766.
  • 11
    Uehara R, Igarashi H, Yashiro M, Nakamura Y, Yanagawa H. Kawasaki disease patients with redness or crust formation at the Bacille Calmette-Guerin inoculation site. Pediatr. Infect. Dis. J. 2010; 29: 430433.
  • 12
    Genizi J, Miron D, Spiegel R, Fink D, Horowitz Y. Kawasaki disease in very young infants: high prevalence of atypical presentation and coronary arteritis. Clin. Pediatr. (Phila) 2003; 42: 263267.
  • 13
    Sudo D, Monobe Y, Yashiro M et al. Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur. J. Pediatr. 2012; 171: 651656.
  • 14
    Yellen ES, Gauvreau K, Takahashi M et al. Performance of 2004 American Heart Association recommendations for treatment of Kawasaki disease. Pediatrics 2010; 125: e234241.
  • 15
    Heuclin T, Dubos F, Hue V et al. Increased detection rate of Kawasaki disease using new diagnostic algorithm, including early use of echocardiography. J. Pediatr. 2009; 155: 6959 e1.
  • 16
    Zulian F, Falcini F, Zancan L et al. Acute surgical abdomen as presenting manifestation of Kawasaki disease. J. Pediatr. 2003; 142: 731735.
  • 17
    Burgner D, Festa M, Isaacs D. Delayed diagnosis of Kawasaki disease presenting with massive lymphadenopathy and airway obstruction. BMJ 1996; 312: 14711472.
  • 18
    Husain E, Hoque E. Meningoencephalitis as a presentation of Kawasaki disease. J. Child Neurol. 2006; 21: 10801081.
  • 19
    Farvardin M, Kashef S, Aleyasin S, Nabavizadeh SH, Sajjadi M, Safari M. Sudden unilateral blindness in a girl with Kawasaki disease. J. Pediatr. Ophthalmol. Strabismus 2007; 44: 303304.
  • 20
    Sundel RP, Newburger JW, McGill T et al. Sensorineural hearing loss associated with Kawasaki disease. J. Pediatr. 1990; 117: 371377.
  • 21
    Knott PD, Orloff LA, Harris JP, Novak RE, Burns JC. Sensorineural hearing loss and Kawasaki disease: a prospective study. Am. J. Otolaryngol. 2001; 22: 343348.
  • 22
    Wright H, Waddington C, Geddes J, Newburger JW, Burgner D. Facial nerve palsy complicating Kawasaki disease. Pediatrics 2008; 122: e783785.
  • 23
    Ozdogu H, Boga C. Fatal cardiac tamponade in a patient with Kawasaki disease. Heart Lung 2005; 34: 257259.
  • 24
    Fukunaga S, Egashira A, Arinaga K et al. Aortic valve replacement for aortic regurgitation due to Kawasaki disease. Report of two cases. J. Heart Valve Dis. 1996; 5: 231234.
  • 25
    Erez E, Kanter KR, Isom E, Williams WH, Tam VK. Mitral valve replacement in children. J. Heart Valve Dis. 2003; 12: 2529; discussion 30.
  • 26
    Sumitomo N, Karasawa K, Taniguchi K et al. Association of sinus node dysfunction, atrioventricular node conduction abnormality and ventricular arrhythmia in patients with Kawasaki disease and coronary involvement. Circ. J. 2008; 72: 274280.
  • 27
    Crystal MA, Syan SK, Yeung RS, Dipchand AI, McCrindle BW. Echocardiographic and electrocardiographic trends in children with acute Kawasaki disease. Can. J. Cardiol. 2008; 24: 776780.
  • 28
    Haney I, Beghetti M, McCrindle BW, Gow RM. Ventricular arrhythmia complicating Kawasaki disease. Can. J. Cardiol. 1995; 11: 931933.
  • 29
    Davies HD, Kirk V, Jadavji T, Kotzin BL. Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Pediatr. Infect. Dis. J. 1996; 15: 11361138.
  • 30
    Kanegaye JT, Wilder MS, Molkara D et al. Recognition of a Kawasaki disease shock syndrome. Pediatrics 2009; 123: e783789.
  • 31
    Yim D, Ramsay J, Kothari D, Burgner D. Coronary artery dilatation in toxic shock-like syndrome: the Kawasaki disease shock syndrome. Pediatr. Cardiol. 2010; 31: 12321235.
  • 32
    Uehara R, Belay ED, Maddox RA et al. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr. Infect. Dis. J. 2008; 27: 155160.
  • 33
    Mine K, Takaya J, Hasui M, Ikemoto Y, Teraguchi M, Kobayashi Y. A case of Kawasaki disease associated with syndrome of inappropriate secretion of antidiuretic hormone. Acta Paediatr. 2004; 93: 15471549.
  • 34
    Nakamura Y, Yashiro M, Uehara R et al. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr. Int. 2004; 46: 3338.
  • 35
    Eladawy M, Dominguez SR, Anderson MS, Glode MP. Abnormal liver panel in acute Kawasaki disease. Pediatr. Infect. Dis. J. 2011; 30: 141144.
  • 36
    Chiang AN, Hwang B, Shaw GC et al. Changes in plasma levels of lipids and lipoprotein composition in patients with Kawasaki disease. Clin. Chim. Acta 1997; 260: 1526.
  • 37
    Gupta-Malhotra M, Gruber D, Abraham SS et al. Atherosclerosis in survivors of Kawasaki disease. J. Pediatr. 2009; 155: 572577.
  • 38
    Sato YZ, Molkara DP, Daniels LB et al. Cardiovascular biomarkers in acute Kawasaki disease. Int. J. Cardiol. 2013; 164: 5863.
  • 39
    Dahdah N, Siles A, Fournier A et al. Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr. Cardiol. 2009; 30: 810817.
  • 40
    McNeal-Davidson A, Fournier A, Spigelblatt L et al. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease. Pediatr. Int. 2012; 54: 627633.
  • 41
    Foell D, Ichida F, Vogl T et al. S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet 2003; 361: 12701272.
  • 42
    Takatsuki S, Ito Y, Takeuchi D et al. IVIG reduced vascular oxidative stress in patients with Kawasaki disease. Circ. J. 2009; 73: 13151318.
  • 43
    Manlhiot C, Millar K, Golding F, McCrindle BW. Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr. Cardiol. 2010; 31: 242249.
  • 44
    Newburger JW, Takahashi M, Beiser AS et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N. Engl. J. Med. 1991; 324: 16331639.
  • 45
    Burns JC. Kawasaki disease. Adv. Pediatr. 2001; 48: 157177.
  • 46
    Muta H, Ishii M, Egami K et al. Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan. J. Pediatr. 2004; 144: 496499.
  • 47
    Manlhiot C, Yeung RS, Chahal N, McCrindle BW. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease. Pediatr. Allergy Immunol. 2010; 21: 515521.
  • 48
    Baumer JH, Love SJ, Gupta A, Haines LC, Maconochie I, Dua JS. Salicylate for the treatment of Kawasaki disease in children. Cochrane Database Syst. Rev. 2006; (4): CD004175.
  • 49
    Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Pediatrics 2004; 114: e689693.
  • 50
    Durongpisitkul K, Gururaj VJ, Park JM, Martin CF. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 1995; 96: 10571061.
  • 51
    Royal Children's Hospital. Clinical Practice Guideline on Kawasaki Disease. Royal Children's Hospital: Melbourne, Australia, 2012. Available from: [accessed April 2013].
  • 52
    Catella-Lawson F, Reilly MP, Kapoor SC et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N. Engl. J. Med. 2001; 345: 18091817.
  • 53
    Anzellotti P, Capone ML, Jeyam A et al. Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences. Arthritis Rheum. 2011; 63: 850859.
  • 54
    Suda K, Kudo Y, Higaki T et al. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. Circ. J. 2009; 73: 13191323.
  • 55
    Newburger JW, Sleeper LA, McCrindle BW et al. Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N. Engl. J. Med. 2007; 356: 663675.
  • 56
    Zhu BH, Lv HT, Sun L et al. A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease. Eur. J. Pediatr. 2012; 171: 571578.
  • 57
    Kobayashi T, Saji T, Otani T et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet 2012; 379: 16131620.
  • 58
    Son MB, Newburger JW. Management of Kawasaki disease: corticosteroids revisited. Lancet 2012; 379: 15711572.
  • 59
    Curtis N. Prednisolone added to intravenous immunoglobulin treatment improves outcome in children with severe Kawasaki disease. Arch. Dis. Child Educ. Pract. Ed. 2013; 98: 7778.
  • 60
    Freeman AF, Shulman ST. Refractory Kawasaki disease. Pediatr. Infect. Dis. J. 2004; 23: 463464.
  • 61
    Kobayashi T, Inoue Y, Takeuchi K et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006; 113: 26062612.
  • 62
    Egami K, Muta H, Ishii M et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J. Pediatr. 2006; 149: 237240.
  • 63
    Maury CP, Salo E, Pelkonen P. Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease. J. Lab. Clin. Med. 1989; 113: 651654.
  • 64
    Hirono K, Kemmotsu Y, Wittkowski H et al. Infliximab reduces the cytokine-mediated inflammation but does not suppress cellular infiltration of the vessel wall in refractory Kawasaki disease. Pediatr. Res. 2009; 65: 696701.
  • 65
    Burns JC, Best BM, Mejias A et al. Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease. J. Pediatr. 2008; 153: 833838.
  • 66
    Song MS, Lee SB, Sohn S et al. Infliximab treatment for refractory Kawasaki disease in Korean children. Korean Circ. J. 2010; 40: 334338.
  • 67
    Choueiter NF, Olson AK, Shen DD, Portman MA. Prospective open-label trial of etanercept as adjunctive therapy for Kawasaki disease. J. Pediatr. 2010; 157: 960961.
  • 68
    McCandless RT, Minich LL, Tani LY, Williams RV. Does abciximab promote coronary artery remodeling in patients with Kawasaki disease? Am. J. Cardiol. 2010; 105: 16251628.
  • 69
    Huang SM, Weng KP, Chang JS, Lee WY, Huang SH, Hsieh KS. Effects of statin therapy in children complicated with coronary arterial abnormality late after Kawasaki disease: a pilot study. Circ. J. 2008; 72: 15831587.
  • 70
    Vuorio A, Kuoppala J, Kovanen PT et al. Statins for children with familial hypercholesterolemia. Cochrane Database Syst. Rev. 2010; (7): CD006401.
  • 71
    Mueller F, Knirsch W, Harpes P, Pretre R, Valsangiacomo Buechel E, Kretschmar O. Long-term follow-up of acute changes in coronary artery diameter caused by Kawasaki disease: risk factors for development of stenotic lesions. Clin. Res. Cardiol. 2009; 98: 501507.
  • 72
    Greil GF, Stuber M, Botnar RM et al. Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease. Circulation 2002; 105: 908911.
  • 73
    Kanamaru H, Sato Y, Takayama T et al. Assessment of coronary artery abnormalities by multislice spiral computed tomography in adolescents and young adults with Kawasaki disease. Am. J. Cardiol. 2005; 95: 522525.
  • 74
    Arnold R, Ley S, Ley-Zaporozhan J et al. Visualization of coronary arteries in patients after childhood Kawasaki syndrome: value of multidetector CT and MR imaging in comparison to conventional coronary catheterization. Pediatr. Radiol. 2007; 37: 9981006.
  • 75
    Cantin L, Chartrand-Lefebvre C, Marcotte F, Pressacco J, Ducharme A, Lapierre C. Coronary artery noninvasive imaging in adult Kawasaki disease. Clin. Imaging 2009; 33: 181187.
  • 76
    Kashyap R, Mittal BR, Bhattacharya A, Manojkumar R, Singh S. Exercise myocardial perfusion imaging to evaluate inducible ischaemia in children with Kawasaki disease. Nucl. Med. Commun. 2011; 32: 137141.
  • 77
    Zilberman MV, Goya G, Witt SA, Glascock B, Kimball TR. Dobutamine stress echocardiography in the evaluation of young patients with Kawasaki disease. Pediatr. Cardiol. 2003; 24: 338343.
  • 78
    Mitani Y, Ohashi H, Sawada H et al. In vivo plaque composition and morphology in coronary artery lesions in adolescents and young adults long after Kawasaki disease: a virtual histology-intravascular ultrasound study. Circulation 2009; 119: 28292836.
  • 79
    Ishii M, Ueno T, Ikeda H et al. Sequential follow-up results of catheter intervention for coronary artery lesions after Kawasaki disease: quantitative coronary artery angiography and intravascular ultrasound imaging study. Circulation 2002; 105: 30043010.
  • 80
    Gurofsky RC, Sabharwal T, Manlhiot C et al. Arterial complications associated with cardiac catheterization in pediatric patients with a previous history of Kawasaki disease. Catheter. Cardiovasc. Interv. 2009; 73: 809813.
  • 81
    Yamauchi H, Ochi M, Fujii M et al. Optimal time of surgical treatment for Kawasaki coronary artery disease. J. Nippon Med. Sch. 2004; 71: 279286.
  • 82
    Kitamura S, Tsuda E, Kobayashi J et al. Twenty-five-year outcome of pediatric coronary artery bypass surgery for Kawasaki disease. Circulation 2009; 120: 6068.
  • 83
    Kato H, Ichinose E, Yoshioka F et al. Fate of coronary aneurysms in Kawasaki disease: serial coronary angiography and long-term follow-up study. Am. J. Cardiol. 1982; 49: 17581766.
  • 84
    Senzaki H. Long-term outcome of Kawasaki disease. Circulation 2008; 118: 27632772.
  • 85
    Samada K, Shiraishi H, Sato A, Momoi MY. Grown-up Kawasaki disease patients who have giant coronary aneurysms. World J. Pediatr. 2010; 6: 3842.
  • 86
    Niboshi A, Hamaoka K, Sakata K, Yamaguchi N. Endothelial dysfunction in adult patients with a history of Kawasaki disease. Eur. J. Pediatr. 2008; 167: 189196.
  • 87
    Ikemoto Y, Ogino H, Teraguchi M, Kobayashi Y. Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr. Cardiol. 2005; 26: 782786.
  • 88
    Cheung YF, Wong SJ, Ho MH. Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease. Arch. Dis. Child. 2007; 92: 4347.
  • 89
    Cheung YF, Ho MH, Tam SC, Yung TC. Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart 2004; 90: 12811285.
  • 90
    Ooyanagi R, Fuse S, Tomita H et al. Pulse wave velocity and ankle brachial index in patients with Kawasaki disease. Pediatr. Int. 2004; 46: 398402.
  • 91
    Cicala S, Pellegrino T, Storto G et al. Noninvasive quantification of coronary endothelial function by SPECT imaging in children with a history of Kawasaki disease. Eur. J. Nucl. Med. Mol. Imaging 2010; 37: 22492255.
  • 92
    Carlton-Conway D, Ahluwalia R, Henry L, Michie C, Wood L, Tulloh R. Behaviour sequelae following acute Kawasaki disease. BMC Pediatr. 2005; 5: 14.
  • 93
    Kavey RE, Allada V, Daniels SR et al. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2006; 114: 27102738.
  • 94
    Gomard-Mennesson E, Landron C, Dauphin C et al. Kawasaki disease in adults: report of 10 cases. Medicine (Baltimore) 2010; 89: 149158.
  • 95
    Wolff AE, Hansen KE, Zakowski L. Acute Kawasaki disease: not just for kids. J. Gen. Intern. Med. 2007; 22: 681684.
  • 96
    Stankovic K, Miailhes P, Bessis D, Ferry T, Broussolle C, Seve P. Kawasaki-like syndromes in HIV-infected adults. J. Infect. 2007; 55: 488494.
  • 97
    Velez AP, Menezes L, Crespo A. Kawasaki-like syndrome possibly associated with immune reconstitution inflammatory syndrome in an HIV-positive patient. AIDS Read. 2006; 16: 464466.
  • 98
    Seve P, Stankovic K, Smail A, Durand DV, Marchand G, Broussolle C. Adult Kawasaki disease: report of two cases and literature review. Semin. Arthritis Rheum. 2005; 34: 785792.